Delivery Order SPE2DB24D8002-SPE2DB24FJMPS
Award Date
7/17/24
Potential Completion Date
8/7/24
Potential Value
$3.6K
Federal Agency
Defense Logistics Agency
Awardee
Dakota Drug, Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business. The $1,755.68 firm fixed-price contract is for the delivery of PROQUAD VIALS, a type of pharmaceutical product, with a performance period ending on December 21, 2023. Dakota Drug, Inc. holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA as part of the ECAT Generation V Program, which allows...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $1,755.73, is for the delivery of PROQUAD VIALS, a pharmaceutical product. The contract is a firm-fixed-price Delivery Order with a period of performance through May 2, 2023. Dakota Drug, Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, which allows the company to provide a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The contract is part of the DLA Troop Support Medical's ECAT Generation V Program and has a ceiling value of $3,679.78. It covers the delivery of PROQUAD VIALS, a pharmaceutical product, through June 4, 2025. Dakota Drug, Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, which...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of PROQUAD VIALS, a medical product, and has a ceiling value of $5,758.90. The contract is a Firm Fixed Price, Delivery Order type, with a period of performance through September 19, 2024. Dakota Drug, Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA, identified as...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of PROQUAD VIALS. The fixed-price contract has a ceiling value of $5,162.20 and a performance period through August 22, 2022. Dakota Drug, Inc. has a larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, as part of the ECAT Generation V Program to provide a range of pharmaceutical...
The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Dakota Drug, Inc., a self-certified small disadvantaged business, for the procurement of PROQUAD vials. The $2,580.94 contract has an ultimate completion date of January 17, 2023. Dakota Drug, Inc. is a key supplier to the DLA Troop Support Medical division, holding a $999,999,999.00 Indefinite Delivery Contract (IDC) as part of the DLA's ECAT Generation V Program, which...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, with a ceiling value of $3,231.24, is for the delivery of PROQUAD VIALS, a type of medical supply. The contract has an ultimate completion date of September 1, 2022. Dakota Drug, Inc. is a key supplier to the DLA, holding a significant Indefinite Delivery Contract (IDC) valued at $999,999,999.00 as part of the DLA...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The $3,611.72 firm fixed-price delivery order is for the provision of PROQUAD VIALS, a pharmaceutical product, to support U.S. Armed Forces medical operations. The contract is associated with Dakota Drug, Inc.'s larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA,...
This federal contract award, with ID SPE2DB24D8001|SPE2DB25FKZHK, was issued by the Defense Logistics Agency (DLA) to the prime contractor Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of PROQUAD VIALS, which are likely pharmaceutical products or medical supplies. It is a firm fixed-price delivery order contract with a ceiling value of $1,836.34 and a period of performance extending to March 26, 2025. Dakota Drug, Inc. holds a significant...
This is a firm fixed-price delivery order contract awarded to Dakota Drug, Inc., a self-certified small disadvantaged business, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is valued at $5,770.10 and has a period of performance through June 25, 2024. The contract is for the delivery of PROQUAD VIALS, a pharmaceutical product, to support the medical supply chain operations of the U.S. Armed Forces. The contract was awarded without a set-aside designation, indicating...